These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36340630)

  • 1. Assessment of an In-Sourced Patient Assistance Program at a Health System in West Virginia.
    Parmiter C; Cecere D; Czyzewski S; Gibson M
    Hosp Pharm; 2022 Dec; 57(6):734-736. PubMed ID: 36340630
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Prescription-Assistance Program for Medically Uninsured Patients With Cancer: Case Study of a Public Hospital Experience in New York State.
    Gao L; Joseph J; Santoro-Levy M; Gotlieb VK; Multz AS
    J Oncol Pract; 2014 Mar; 10(2):104. PubMed ID: 29452556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Pharmaceutical Patient and Prescription Assistance Programs via a Pharmacy Department Patient Assistance Program for Indigent Cancer Patients.
    Gao L; Joseph J; Santoro-Levy M; Multz AS; Gotlieb VK
    Hosp Pharm; 2016 Jul; 51(7):572-6. PubMed ID: 27559190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical manufacturer assistance programs.
    Chisholm MA; DiPiro JT
    Arch Intern Med; 2002 Apr; 162(7):780-4. PubMed ID: 11926851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
    Pauly NJ; Talbert JC; Brown J
    J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization.
    Burley MH; Daratha KB; Tuttle K; White JR; Wilson M; Armstrong K; McPherson S; Selinger S
    J Manag Care Spec Pharm; 2016 Apr; 22(4):381-7. PubMed ID: 27023691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a patient medication assistance program in a community pharmacy setting.
    Mounts VL; Ringenberg DG; Rhees K; Partridge C
    J Am Pharm Assoc (2003); 2005; 45(1):76-81. PubMed ID: 15730120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program.
    Weiner S; Dischler J; Horvitz C
    Am J Health Syst Pharm; 2001 Jan; 58(2):146-50. PubMed ID: 11202538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing clinical pharmacists and a medication assistance program to improve medication access for indigent and underserved patients in primary care.
    Pickett B; Shin TR; Norton M
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100211. PubMed ID: 36582998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-benefit analysis of a clinical pharmacist-managed medication assistance program in a renal transplant clinic.
    Chisholm MA; Vollenweider LJ; Mulloy LL; Wynn JJ; Wade WE; DiPiro JT
    Clin Transplant; 2000 Aug; 14(4 Pt 1):304-7. PubMed ID: 10945200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial Eligibility Criteria and Medication Coverage for Independent Charity Patient Assistance Programs.
    Kang SY; Sen A; Bai G; Anderson GF
    JAMA; 2019 Aug; 322(5):422-429. PubMed ID: 31386135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication assistance programs for uninsured and indigent patients.
    Chisholm MA; Reinhardt BO; Vollenweider LJ; Kendrick BD; DiPiro JT
    Am J Health Syst Pharm; 2000 Jun; 57(12):1131-6. PubMed ID: 10911511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of embedded medication assistance program specialists on medication access in outpatient oncology clinics.
    Fudzie SS; Luong B; Jean SJ; Francart SJ
    J Oncol Pharm Pract; 2021 Dec; 27(8):1829-1834. PubMed ID: 33121352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.
    Buckley BC; Roylance D; Mitchell MP; Patel SM; Cannon HE; Dunn JD
    J Manag Care Pharm; 2010; 16(1):15-22. PubMed ID: 20044843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ensuring access to prescription medications in the post-ACA healthcare access landscape: the essential role of FQHCs in the safety net for the underinsured.
    Shi L; Wharton MK; Monnette A
    Am J Manag Care; 2018 Mar; 24(5 Suppl):S67-S73. PubMed ID: 29620813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S13-7. PubMed ID: 17057055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial Hardship from Purchasing Medications for Senior Citizens Before and After the Medicare Modernization Act of 2003 and the Patient Protection and Affordable Care Act of 2010: Findings from 1998, 2001, and 2015.
    Olson AW; Schommer JC; Mott DA; Brown LM
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1150-8. PubMed ID: 27668563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.